Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry

被引:10
|
作者
Zubaid, Mohammad [1 ]
Khraishah, Haitham [2 ]
Alahmad, Barrak [3 ]
Rashed, Wafa [4 ]
Ridha, Mustafa [5 ]
Alenezi, Fahad [6 ]
Aljarralah, Mohamad [7 ]
Al-Marri, Khalid [8 ]
Almutairi, Mohammad [9 ]
Althalji, Khalid [6 ]
Alfaddagh, Abdulhamied [10 ]
机构
[1] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait
[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA
[3] Harvard Univ, TH Chan Sch Publ Hlth, Environm Hlth Dept, Boston, MA 02115 USA
[4] Minist Hlth, Dept Med, Div Cardiol, Mubarak Alkabeer Hosp, Kuwait, Kuwait
[5] Minist Hlth, Dept Cardiol, Salman Aldabous Cardiac Ctr, Kuwait, Kuwait
[6] Minist Hlth, Dept Med, Div Cardiol, Alfarwaniya Hosp, Kuwait, Kuwait
[7] Minist Hlth, Dept Cardiol, Sabah Alahmad Cardiac Ctr, Kuwait, Kuwait
[8] Minist Hlth, Dept Cardiol, Chest Dis Hosp, Kuwait, Kuwait
[9] Aljahra Hosp, Dept Med, Div Cardiol, Kuwait, Kuwait
[10] Johns Hopkins Univ, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
来源
ANNALS OF GLOBAL HEALTH | 2020年 / 86卷 / 01期
关键词
GULF REGISTRY; TASK-FORCE; REPERFUSION; OUTCOMES; DELAYS; FIBRINOLYSIS; GUIDELINES; EXPERIENCE; TRENDS; PCI;
D O I
10.5334/aogh.2632
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A pharmacoinvasive reperfusion strategy is recommended for ST-elevation myocardial infarction (STEMI) patients when primary percutaneous coronary intervention (PCI) cannot be achieved in a timely fashion. This is based on a limited number of trials. The effectiveness of this strategy in the real-world is unclear. Objectives: To compare the effectiveness of pharmacoinvasive strategy versus primary PCI using a nationwide prospective registry of STEMI patients. Methods: We examined 936 STEMI patients from the reperfusion in ST-elevation myocardial infarction in Kuwait (REPERFUSE Kuwait) registry who underwent either primary PCI or pharmacoinvasive reperfusion. A composite outcome was measured based on death, congestive heart failure, reinfarction or stroke prospectively ascertained during hospital stay and up to one-year follow-up. The association between reperfusion strategy and the composite outcome was assessed using multivariate regression and Poisson proportional hazard model. Results: Compared to the pharmacoinvasive group, those undergoing primary PCI had higher Killip class on presentation and required more blood transfusions during hospitalization. There was no significant difference between primary PCI and pharmacoinvasive strategy with regards to the incidence of the composite outcome during the in-hospital period (RR = 1.0; 95% CI 0.98-1.02; p = 0.96) after adjustment for possible confounders. Over one-year follow-up, the survival of the two groups was not different (p = 0.66). The incidence of major bleeding was similar in both groups. Conclusion: STEMI patients treated with a pharmacoinvasive strategy have comparable outcomes to those treated with primary PCI with no increased risk of major bleeding. These real-world data support the use of a pharmacoinvasive strategy when primary PCI cannot be achieved in a timely fashion.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Outcomes of Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction in Kurdistan Region of Iraq
    Mohammad, Ameen M.
    Mohammed, Schivan U.
    Saeed, Saad Y.
    JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2022, 8 (02): : 120 - 127
  • [42] Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
    Eitel, Ingo
    Woehrle, Jochen
    Suenkel, Henning
    Meissner, Josephine
    Kerber, Sebastian
    Lauer, Bernward
    Pauschinger, Matthias
    Birkemeyer, Ralf
    Axthelm, Christoph
    Zimmermann, Rainer
    Neuhaus, Petra
    Brosteanu, Oana
    de Waha, Suzanne
    Desch, Steffen
    Gutberlet, Matthias
    Schuler, Gerhard
    Thiele, Holger
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (13) : 1447 - 1454
  • [43] The efficacy and safety of transradial percutaneous coronary intervention VS transfemoral percutaneous coronary intervention for ST-segment elevation myocardial infarction patients: A meta-analysis
    Pang, Jun
    Zhang, Zheng
    Yang, Yue-jin
    Li, Na
    Bai, Min
    Peng, Yu
    Zhang, Jin
    Li, Qiang
    Zhang, Bo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (02) : 483 - 488
  • [44] Pharmacoinvasive Strategy for ST-Segment Elevation Myocardial Infarction Wading Through the Treatment Options
    Abbott, J. Dawn
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2010, 3 (04) : 294 - 296
  • [45] Prognostic Implications of ST-Segment Elevation Resolution in Patients With ST-Segment Elevation Acute Myocardial Infarction Treated With Primary or Facilitated Percutaneous Coronary Intervention
    Palmerini, Tullio
    De Servi, Stefano
    Politi, Alessandro
    Martinoni, Alessandro
    Musumeci, Giuseppe
    Ettori, Federica
    Piccaluga, Emanuela
    Sangiorgi, Diego
    Lauria, Giulia
    Repetto, Alessandra
    Castiglioni, Battistina
    Fabbiocchi, Franco
    Onofri, Marco
    De Cesare, Nicoletta
    D'Urbano, Maurizio
    Poletti, Fabrizio
    Sangiorgi, Giuseppe
    Zanini, Roberto
    Lettieri, Corrado
    Belli, Guido
    Pirelli, Salvatore
    Klugmann, Silvio
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (05): : 605 - 610
  • [46] Role of percutaneous coronary minimalist intervention in the management of acute ST-segment elevation myocardial infarction - Reply
    Sianos, Georgios
    Papafaklis, Michail I.
    Daemen, Joost
    Vaina, Sofia
    van Mieghem, Carlos A.
    van Domburg, Ron T.
    Michalis, Larnpros K.
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : 1047 - 1047
  • [47] Primary Perfusion Balloon Angioplasty in Primary Percutaneous Coronary Intervention for St-Segment Elevation Myocardial Infarction - The Novel Cardioprotective Revascularization Strategy
    Nakanishi, Toru
    Koto, Dan
    Kasahara, Mizuho
    Mizukoshi, Kei
    Takano, Makoto
    Mizuno, Koichi
    Matsuda, Hisao
    Akashi, Yoshihiro J.
    CIRCULATION, 2022, 146
  • [48] Use of bivalirudin during percutaneous coronary intervention for ST-Segment elevation myocardial infarction
    Muniz, A. J.
    Loures, J. B.
    Pimentel, R. C.
    Ramalho, G. M.
    Loures, J. G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 26C - 26C
  • [49] Interhospital Transfer of Patients With ST-Segment Elevation Myocardial Infarction for Percutaneous Coronary Intervention
    Tsai, Fausan S.
    Mellana, William M.
    Aronow, Wilbert S.
    Ahn, Chul
    Ferraris, Ambra
    Dudha, Majid
    Kalapatapu, Kumar
    Pucillo, Anthony L.
    Monsen, Craig E.
    AMERICAN JOURNAL OF THERAPEUTICS, 2010, 17 (06) : E189 - E192
  • [50] Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis
    Sim, Doo Sun
    Jeong, Myung Ho
    Ahn, Youngkeun
    Kim, Young Jo
    Chae, Shung Chull
    Hong, Taek Jong
    Seong, In Whan
    Chae, Jei Keon
    Kim, Chong Jin
    Cho, Myeong Chan
    Rha, Seung-Woon
    Bae, Jang Ho
    Seung, Ki Bae
    Park, Seung Jung
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (09)